NHS hospital trusts in London are trialing an AI system, Aire-DM, to predict type 2 diabetes up to a decade before it develops by analyzing ECG heart traces. Clinical trials planned for 2025 aim to confirm its efficacy, which early research suggests can identify risk in 70% of cases. By incorporating additional factors like age, sex, and existing health conditions, the AI's accuracy is improved. Funded by the British Heart Foundation, this innovation could revolutionize early detection and prevention efforts. Experts highlight the potential to prevent serious conditions linked to diabetes, such as heart disease and sight loss.